BDSX

BIODESIX INC

BIODESIX INC (BDSX) has 7 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 2, 2026.

  • Industry:Medical - Diagnostics & Research
  • CEO:Scott Hutton
  • Employees:334
  • HQ:Boulder, CO, US
  • IPO:2020-10-28

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$43K

reported sales (SEC code S)

Unique Insiders

5

in the rolling window

Market Cap

$230.0M

latest known value

Source
Hutton ScottFirst filing
Sale$19KFeb 23SEC ↗
Cowie Robin HarperFirst filing
Sale$7KFeb 23SEC ↗
Vazquez ChrisFirst filing
Sale$3KFeb 23SEC ↗
Sale$7KFeb 23SEC ↗
O'Kane KieranFirst filing
Sale$7KFeb 23SEC ↗

Related companies

BIODESIX INC is in the Healthcare sector.